Literature DB >> 29892188

Cefazolin Induced Liver Injury and Hypoprothrombinemia.

Ankur Gupta1, Anil K Singh2, Khursheed Faridi3, Priyanka Jain4.   

Abstract

Entities:  

Year:  2018        PMID： 29892188      PMCID： PMC5992318          DOI： 10.1016/j.jceh.2017.12.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  6 in total

Review 1.  Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports.

Authors:  Einar S Björnsson; Jay H Hoofnagle
Journal:  Hepatology       Date:  2015-12-21       Impact factor: 17.425

2.  Letter: Coagulopathy with cefazolin in uremia.

Authors:  P I Lerner; A Lubin
Journal:  N Engl J Med       Date:  1974-06-06       Impact factor: 91.245

3.  Influence of cephalosporin antibiotics on blood coagulation and platelet function.

Authors:  E A Natelson; C H Brown; M W Bradshaw; C P Alfrey; T W Williams
Journal:  Antimicrob Agents Chemother       Date:  1976-01       Impact factor: 5.191

4.  Identification and Characterization of Cefazolin-Induced Liver Injury.

Authors:  Saleh A Alqahtani; David E Kleiner; Marwan Ghabril; Jiezhun Gu; Jay H Hoofnagle; Don C Rockey
Journal:  Clin Gastroenterol Hepatol       Date:  2014-12-18       Impact factor: 11.382

5.  Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries.

Authors:  G Danan; C Benichou
Journal:  J Clin Epidemiol       Date:  1993-11       Impact factor: 6.437

6.  Use of Hypoprothrombinemia-Inducing Cephalosporins and the Risk of Hemorrhagic Events: A Nationwide Nested Case-Control Study.

Authors:  Li-Ju Chen; Fei-Yuan Hsiao; Li-Jiuan Shen; Fe-Lin Lin Wu; Woei Tsay; Chien-Ching Hung; Shu-Wen Lin
Journal:  PLoS One       Date:  2016-07-27       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.